ATE475096T1 - Unterscheidung zwischen baktiereller meningitis und viraler meningitis - Google Patents

Unterscheidung zwischen baktiereller meningitis und viraler meningitis

Info

Publication number
ATE475096T1
ATE475096T1 AT06841938T AT06841938T ATE475096T1 AT E475096 T1 ATE475096 T1 AT E475096T1 AT 06841938 T AT06841938 T AT 06841938T AT 06841938 T AT06841938 T AT 06841938T AT E475096 T1 ATE475096 T1 AT E475096T1
Authority
AT
Austria
Prior art keywords
meningitis
present
procalcitonin
viral
relates
Prior art date
Application number
AT06841938T
Other languages
English (en)
Inventor
Martin Chalumeau
Francois Dubos
Dominique Gendrel
Gerard Breart
Original Assignee
Assist Publ Hopitaux De Paris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36218072&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE475096(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Assist Publ Hopitaux De Paris filed Critical Assist Publ Hopitaux De Paris
Application granted granted Critical
Publication of ATE475096T1 publication Critical patent/ATE475096T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664—Blood serum or blood plasma standard or control

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT06841938T 2005-12-14 2006-12-14 Unterscheidung zwischen baktiereller meningitis und viraler meningitis ATE475096T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0512687A FR2894675B1 (fr) 2005-12-14 2005-12-14 Distinction des meningites bacteriennes et virales
PCT/FR2006/002734 WO2007068830A1 (fr) 2005-12-14 2006-12-14 Distinction des meningites bacteriennes et virales

Publications (1)

Publication Number Publication Date
ATE475096T1 true ATE475096T1 (de) 2010-08-15

Family

ID=36218072

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06841938T ATE475096T1 (de) 2005-12-14 2006-12-14 Unterscheidung zwischen baktiereller meningitis und viraler meningitis

Country Status (11)

Country Link
US (1) US8232046B2 (de)
EP (1) EP1977244B1 (de)
AT (1) ATE475096T1 (de)
CA (1) CA2633912A1 (de)
DE (1) DE602006015702D1 (de)
ES (1) ES2352045T3 (de)
FR (1) FR2894675B1 (de)
PL (1) PL1977244T3 (de)
PT (1) PT1977244E (de)
SI (1) SI1977244T1 (de)
WO (1) WO2007068830A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2894675B1 (fr) 2005-12-14 2008-06-27 Assist Publ Hopitaux De Paris Distinction des meningites bacteriennes et virales
GB0711327D0 (en) 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
HUE046182T2 (hu) * 2009-04-14 2020-02-28 Brahms Gmbh Az antibiotikumos kezelés kozkázatának becslése elsõdlegesen nem fertõzõ betegségben szenvedõ betegekben a prokalcitonin szintjének meghatározásával
JP5798133B2 (ja) * 2010-03-08 2015-10-21 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 不特定の愁訴を示す患者における細菌感染及び抗生物質治療の指標を診断するために用いられるプロカルシトニン
GB201016161D0 (en) 2010-09-24 2010-11-10 Hansa Medical Ab Diagnostic method
GB201102108D0 (en) 2011-02-07 2011-03-23 Hansa Medical Ab Diagnostic method
GB201518597D0 (en) * 2015-10-20 2015-12-02 Univ Liverpool Detection of bacterial infection
CN115859174A (zh) * 2023-01-06 2023-03-28 深圳市儿童医院 一种细菌性脑膜炎分类模型构建方法及其在识别脑脊液宏基因组测序假阳性结果中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR512687A (fr) 1919-09-22 1921-01-28 Eugene Carlet De La Roziere Bandage élastique pour roues de véhicules
JP2955082B2 (ja) 1991-10-11 1999-10-04 大阪瓦斯株式会社 ヒトカルシトニンのｎ末端部分を特異的に認識するモノクローナル抗体
US6038286A (en) 1995-11-24 2000-03-14 Teleray Ag Optical arrangement and method for electronically detecting an X-ray image
JP4037933B2 (ja) 1996-12-24 2008-01-23 大阪瓦斯株式会社 抗ヒトカルシトニンモノクローナル抗体
EP1110970B1 (de) 1999-12-22 2008-05-14 Dade Behring Marburg GmbH Gegen Procalcitonin gerichtete Antikörper, ihre Herstellung und Verwendung
ES2280170T3 (es) 1999-12-22 2007-09-16 Dade Behring Marburg Gmbh Soluciones de procalcitonina humana.
FR2894675B1 (fr) 2005-12-14 2008-06-27 Assist Publ Hopitaux De Paris Distinction des meningites bacteriennes et virales

Also Published As

Publication number Publication date
US8232046B2 (en) 2012-07-31
PL1977244T3 (pl) 2011-02-28
CA2633912A1 (fr) 2007-06-21
EP1977244A1 (de) 2008-10-08
EP1977244B1 (de) 2010-07-21
SI1977244T1 (sl) 2011-02-28
US20090221021A1 (en) 2009-09-03
FR2894675B1 (fr) 2008-06-27
FR2894675A1 (fr) 2007-06-15
ES2352045T3 (es) 2011-02-15
PT1977244E (pt) 2010-11-11
WO2007068830A1 (fr) 2007-06-21
DE602006015702D1 (de) 2010-09-02

Similar Documents

Publication Publication Date Title
ATE475096T1 (de) Unterscheidung zwischen baktiereller meningitis und viraler meningitis
ATE538386T1 (de) Nachweis von krebs anhand von erhöhten bcl-2- konzentrationen
GB0510943D0 (en) Improved immunoassay methods
ATE289685T1 (de) Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben
ATE425266T1 (de) Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten
ATE438853T1 (de) Diagnostische testvorrichtung
EP1930445A4 (de) Kit und verfahren zum nachweis von urothelkarzinom
DE602006021777D1 (de) Diagnoseverfahren für präeklampsie
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
ATE471512T1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
DE60315715D1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
GB2437545B (en) Dextrin-containing reagents for detecting and quantifying proteins
ATE492815T1 (de) Diagnostik-biomolekül(e)
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
WO2006066917A3 (en) Use of asc as a marker for colorectal cancer
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
DE602005010548D1 (de) Verbessertes verfahren zur diagnose des akuten koronarsyndroms
WO2002057793A3 (en) Method of detecting prp protein and kits therefor
CY1109461T1 (el) Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου
ATE393393T1 (de) Verwendung des proteins spee als marker für brustkrebs
TW200502399A (en) Recombinant virus and use thereof and method of detecting an analyte in a sample and kit thereof
WO2012020402A3 (en) Sensor for detection and identification of analytes and a method thereof
DE602004017017D1 (de) Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome
WO2008148492A8 (en) Neurofilamental proteins as biomarker for alzheimer's disease

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1977244

Country of ref document: EP